{
    "clinical_study": {
        "@rank": "36999", 
        "arm_group": [
            {
                "arm_group_label": "Misoprostol", 
                "arm_group_type": "Experimental", 
                "description": "Women will receive two sub lingual tablets each containing 200 micro gram misoprostol (Misotac), receiving a total dose of 400 micro grams. Two hour later, Cu T 380A IUD (PREGNA) will be inserted."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Women will receive two sub lingual placebo tablets which will be similar in size, color, odor and shape to the misoprostol tablets. Two hour later, Cu T 380A IUD (PREGNA) will be inserted."
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the work is to evaluate the efficacy of the sub lingual prostaglandin E1\n      synthetic analogue (misoprostol) before IUD insertion to facilitate the procedure in\n      patients delivered before only by cesarean section."
        }, 
        "brief_title": "Sub Lingual Misoprostol Before IUD Insertion in Women With Only Previous Cesarean Section", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "IUD Insertion", 
        "detailed_description": {
            "textblock": "The study will be conducted at Ain Shams University Maternity Hospital. 124 women candidate\n      for Cu T 380A IUD insertion will be enrolled in the study. Half of them will receive 400\n      micro gram of misoprostol (Sigma) sub lingually and the other half will receive the placebo\n      two hours before IUD insertion."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Normal size uterus.\n\n          -  Willing to participate.\n\n          -  Candidate for IUD insertion.\n\n          -  Delivered only by cesarean section.\n\n          -  Last delivery is more than 40 days before participating in the study.\n\n        Exclusion Criteria:\n\n          -  Previous vaginal delivery\n\n          -  Signs of genital infection.\n\n          -  Menopause.\n\n          -  Body mass index (BMI) > 35 kg/m2.\n\n          -  Contraindication to misoprostol.\n\n          -  Copper allergy.\n\n          -  Positive pregnancy test.\n\n          -  Had a prior attempt for IUD insertion.\n\n          -  Uterine anomalies.\n\n          -  Uterine fibroid."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "124", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 15, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02141321", 
            "org_study_id": "9010023"
        }, 
        "intervention": [
            {
                "arm_group_label": "Misoprostol", 
                "intervention_name": "Misoprostol", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Misotac", 
                    "Cytotec", 
                    "Misotec", 
                    "Prostaglandin E1 synthetic analogue"
                ]
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Alprostadil", 
                "Misoprostol"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "IUD", 
            "Misoprostol", 
            "Rectal administration"
        ], 
        "lastchanged_date": "May 16, 2014", 
        "location": {
            "contact": {
                "email": "drmsweed@gmail.com", 
                "last_name": "Mohamed S. Sweed, MD", 
                "phone": "01001222047", 
                "phone_ext": "+2"
            }, 
            "facility": {
                "address": {
                    "city": "Cairo", 
                    "country": "Egypt"
                }, 
                "name": "Ain Shams University Maternity Hospital"
            }, 
            "investigator": {
                "last_name": "Mohamed S. Sweed, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_arms": "2", 
        "official_title": "SUB LINGUAL MISOPROSTOL PRIOR TO IUD INSERTION IN WOMEN WITH ONLY PREVIOUS CESARIAN SECTION: A Randomized Controlled Trial", 
        "overall_contact": {
            "email": "drmsweed@gmail.com", 
            "last_name": "Mohamed S. Sweed, MD", 
            "phone": "01001222047", 
            "phone_ext": "+2"
        }, 
        "overall_official": [
            {
                "affiliation": "Ain Shams University", 
                "last_name": "Mohamed S. Sweed, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Ain Shams University", 
                "last_name": "Hassan A. Bayoumy, Professor", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Assiut University", 
                "last_name": "Mohamed Y. Mohamed, M.B., B.Ch.", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Egypt: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The perception of pain and discomfort as described by the patient assessed by Visual Analogue Scale (VAS). The scale will be graded from 0 to 10, 0 representing no pain at all and 10 worst possible imaginable pain.", 
            "measure": "Pain", 
            "safety_issue": "No", 
            "time_frame": "During the procedure"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02141321"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ain Shams University", 
            "investigator_full_name": "Mohamed S Sweed, MD", 
            "investigator_title": "Mohamed S. Sweed lecturer of Obstetrics & Gynecology AinShams University.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "The degree of difficulty of the IUD insertion judged by the investigator as the resistance met at the internal cervical os. The procedure either graded as (easy), (moderate difficulty) or (difficult) or (failed insertion).", 
                "measure": "Difficulty of Procedure", 
                "safety_issue": "No", 
                "time_frame": "During the procedure"
            }, 
            {
                "description": "Uterine perforation, excessive bleeding, fever, IUD expulsion or any other unexpected complications will be assessed during the procedure and followed for the next 24 hours.", 
                "measure": "Complications", 
                "safety_issue": "No", 
                "time_frame": "During the procedure and the following 24 hours."
            }
        ], 
        "source": "Ain Shams University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ain Shams University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator)", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}